Evaluation of immunogenicity and protective efficacy of a plasmid DNA vaccine encoding ribosomal protein L9 of Brucella abortus in BALB/c mice (Q88122128)

From Wikidata

Jump to navigation Jump to search

scientific article published on 17 June 2014

Language	Label	Description	Also known as
English	Evaluation of immunogenicity and protective efficacy of a plasmid DNA vaccine encoding ribosomal protein L9 of Brucella abortus in BALB/c mice	scientific article published on 17 June 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24950353%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Evaluation of immunogenicity and protective efficacy of a plasmid DNA vaccine encoding ribosomal protein L9 of Brucella abortus in BALB/c mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24950353%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Brucella abortus

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24950353%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Prachiti Afley

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24950353%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Sudhir K Dohre

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24950353%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Nandita Saxena

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24950353%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Subodh Kumar

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24950353%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

publication date

17 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24950353%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24950353%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

32

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24950353%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24950353%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

4537-4542

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24950353%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Pathogenesis of bovine brucellosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

B cell-deficient mice display markedly enhanced resistance to the intracellular bacterium Brucella abortus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Biological properties of RB51; a stable rough strain of Brucella abortus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Human illness associated with use of veterinary vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Towards a Brucella vaccine for humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Brucella as a biological weapon.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Potentiation of an anthrax DNA vaccine with electroporation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Bioinformatics analysis of Brucella vaccines and vaccine targets using VIOLIN

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

A DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Increased DNA vaccine delivery and immunogenicity by electroporation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Electroporation improves the efficacy of DNA vaccines in large animals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

In vivo electroporation improves immune responses to DNA vaccination in sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

The prime-boost strategy: exciting prospects for improved vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Prime-boost strategies for malaria vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Identification of a protective protein from stationary-phase exoproteome of Brucella abortus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Th1-type immune response to infection by pYV-cured phoP-phoQ null mutant of Yersinia pseudotuberculosis is defective in mouse model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Recombinant Ochrobactrum anthropi expressing Brucella abortus Cu,Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 type

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Vaccination with recombinant Semliki Forest virus particles expressing translation initiation factor 3 of Brucella abortus induces protective immunity in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Protective effect of a DNA vaccine containing an open reading frame with homology to an ABC-type transporter present in the genomic island 3 of Brucella abortus in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Effects of opsonization and gamma interferon on growth of Brucella melitensis 16M in mouse peritoneal macrophages in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Host immune responses to the intracellular bacteria Brucella: does the bacteria instruct the host to facilitate chronic infection?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Comparison of cytokine immune responses to Brucella abortus and Yersinia enterocolitica serotype O:9 infections in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Immune control of Brucella abortus 2308 infections in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Interferon-gamma associated cytokines and chemokines produced by spleen cells from Brucella-immune mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

The role of T cell subsets and cytokines in the regulation of intracellular bacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

CD8 knockout mice are protected from challenge by vaccination with WR201, a live attenuated mutant of Brucella melitensis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in rams

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

Serologic responses in diagnostic tests for brucellosis in cattle vaccinated with Brucella abortus 19 or RB51

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.012

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2014.06.012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24950353%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24950353%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q88122128&oldid=2122099545"